An assessment of the vulnerability of carotid plaques: a comparative study between intraplaque neovascularization and plaque echogenicity

Yangyang Zhou, Yingqi Xing, Yan Li, Yang Bai, Ying Chen, Xiaofeng Sun, Yingqiao Zhu, Jiang WuBMC Medical Imaging 2013 · DOI

TL;DR

This study investigates the vulnerability of carotid artery plaques, a key factor in stroke risk. It compares two ultrasound techniques: traditional Color Doppler Ultrasonography (CDUS) and Contrast-Enhanced Ultrasound (CEUS). The findings suggest CEUS, by visualizing intraplaque neovascularization, is a more accurate predictor of plaque instability than CDUS's assessment of echogenicity, as indicated by the presence of microembolic signals (MES).

What Problem Does This Paper Address?

Ischemic stroke, often caused by emboli originating from atherosclerotic plaques in the carotid arteries, poses a significant health challenge. Identifying "vulnerable" plaques – those prone to rupture and embolization – is crucial for risk stratification and preventive strategies. Traditional methods like CDUS assess plaque echogenicity as a marker of vulnerability. However, recent advancements suggest that intraplaque neovascularization (the formation of new blood vessels within the plaque) might be a more direct indicator of instability. This paper aims to directly compare the ability of CEUS (which can visualize neovascularization) and CDUS (which assesses echogenicity) to predict plaque vulnerability, using the detection of microembolic signals (MES) during transcranial Doppler monitoring as a proxy for actual embolization events.

Methods

The study involved 46 patients with at least 50% stenosis in their internal carotid artery. All participants underwent three key assessments within a three-day period:

  • Carotid Duplex Ultrasound (CDUS): This standard technique was used to assess plaque morphology, specifically its echogenicity. Plaques were classified into two groups: hyperechoic (Group 1) or hypoechoic (Group 2), based on the modified Gray Weale classification.
  • Contrast-Enhanced Ultrasound (CEUS): This newer technique used an ultrasound contrast agent (SonoVue) to visualize blood flow within the plaque. The presence and extent of intraplaque neovascularization were assessed and categorized into two classes: Class 1 (non-neovascularization) and Class 2 (neovascularization).
  • Transcranial Doppler (TCD) Monitoring of Microembolic Signals (MES): This method monitored for tiny emboli traveling through the cerebral arteries, which are indicative of plaque instability.

The researchers then compared the findings from CEUS and CDUS in relation to the presence of MES, using chi-square tests to determine statistical significance (p < 0.05).

Datasets

The study utilized data from 46 patients undergoing carotid artery assessments. No new datasets were created or introduced. The data collected included patient demographics, clinical history (neurological symptoms, risk factors like hypertension, diabetes, smoking), and the results from the three imaging modalities (CDUS, CEUS, and TCD-MES).

Key Insights and Ideas

  • Neovascularization as a key vulnerability marker: The study strongly suggests that the presence of intraplaque neovascularization, visualized by CEUS, is significantly associated with the occurrence of microembolic signals (MES). This implies that new blood vessel formation within a plaque is a direct indicator of its instability and propensity to shed emboli.
  • CDUS echogenicity's limited predictive power: In contrast to CEUS, traditional CDUS assessment of plaque echogenicity (whether hyperechoic or hypoechoic) did not show a significant correlation with the presence of MES. This challenges the long-held view that echolucency alone is a reliable indicator of plaque vulnerability.
  • CEUS offers a more refined risk assessment: The findings position CEUS as a potentially superior tool for identifying high-risk carotid plaques compared to CDUS. By directly visualizing neovascularization, CEUS may provide more actionable information for clinical decision-making.

Key Results

  • Neovascularization and MES: CEUS identified neovascularization in 30 out of 46 patients (44.4%). Crucially, MES were detected in 50.0% of patients with neovascularization (Class 2) compared to only 12.5% of patients without it (Class 1) (p = 0.023).
  • CDUS echogenicity and MES: CDUS classified plaques as hyperechoic in 28 patients and hypoechoic in 18. However, there was no significant difference in the detection of MES between these two groups (p = 0.237).
  • Clinical characteristics: The study found no significant differences in age, gender, or vascular risk factors between the groups classified by CEUS (neovascularization vs. non-neovascularization) or by CDUS (hyperechoic vs. hypoechoic).

Limitations and Future Work

The authors acknowledge several limitations:

  • Small sample size: The study was a pilot investigation with a relatively small number of participants, which may limit the generalizability of the findings.
  • Semi-quantitative CEUS: The evaluation of contrast enhancement was semi-quantitative, which could be refined with more precise methods.
  • TCD monitoring challenges: Inadequate temporal windows during TCD monitoring prevented MES analysis in some patients, impacting the complete dataset.

Future work should focus on:

  • Larger prospective studies: Validating these findings in larger patient cohorts is essential.
  • Prospective clinical studies: Investigating whether CEUS-detected neovascularization can predict cerebrovascular events and assess the efficacy of anti-atherosclerotic therapies.
  • Quantitative CEUS: Developing and validating more quantitative methods for assessing contrast enhancement.

Summary updated

BibTeX
@article{zhou2013assessment,
  author = {Yangyang Zhou and Yingqi Xing and Yan Li and Yang Bai and Ying Chen and Xiaofeng Sun and Yingqiao Zhu and Jiang Wu},
  title = {{An assessment of the vulnerability of carotid plaques: a comparative study between intraplaque neovascularization and plaque echogenicity}},
  journal = {BMC Medical Imaging},
  year = {2013},
  doi = {10.1186/1471-2342-13-13},
}
Figure